DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trileptal (Oxcarbazepine) - News

 
 



News related to Trileptal (Oxcarbazepine) and/or conditions it is approved for

Fycompa (perampanel) receives European MA for PGTC seizures in patients with idiopathic generalised epilepsy
Source: Epilepsy News From Medical News Today [2015.06.26]
The European Commission (EC) has today granted marketing authorisation approval for Fycompa® (perampanel), for use as a once-daily, adjunctive therapy for primary generalised tonic-clonic...

Scientists identify amino acid that stops seizures in mice
Source: Epilepsy News From Medical News Today [2015.06.22]
Finding suggests novel mechanism for treating epilepsyAn amino acid whose role in the body has been all but a mystery appears to act as a potent seizure inhibitor in mice, according to a study by...

Febrile Seizures
Source: MedicineNet Aches, Pain, Fever Specialty [2015.06.08]
Title: Febrile Seizures
Category: Diseases and Conditions
Created: 5/9/2008 12:00:00 AM
Last Editorial Review: 6/8/2015 12:00:00 AM

Recommendations address how to manage seizures in infants
Source: Epilepsy News From Medical News Today [2015.06.03]
New recommendations offer insights on strategies for treating infants with seizures.

First Aid for Seizures
Source: MedicineNet First Aid Specialty [2015.05.04]
Title: First Aid for Seizures
Category: Procedures and Tests
Created: 1/31/2005 12:00:00 AM
Last Editorial Review: 5/4/2015 12:00:00 AM

Antidepressants Linked to First-Time Seizures
Source: MedicineNet bupropion Specialty [2015.04.09]
Title: Antidepressants Linked to First-Time Seizures
Category: Health News
Created: 4/9/2015 12:00:00 AM
Last Editorial Review: 4/9/2015 12:00:00 AM

FDA Okays New Indication for Perampanel (Fycompa) in Epilepsy
Source: Medscape NeurologyHeadlines [2015.06.22]
Perampanel, already approved for focal seizures, is now indicated as adjunctive therapy for primary generalized tonic-clonic seizures in patients with epilepsy 12 years of age and older.
FDA Approvals

Oxidative stress is an aggravating factor in Lafora rare disease
Source: Epilepsy News From Medical News Today [2015.05.22]
Neurodegenerative Lafora disease usually becomes apparent through seizures during adolescence and puberty and occurs as a consequence of defects in glycogen metabolism and in the cellular...

Epilepsy drug could protect eyesight of MS patients
Source: Epilepsy News From Medical News Today [2015.04.19]
An anticonvulsant drug used to prevent seizures could protect people with MS from some of the damage caused by acute optic neuritis.

Marijuana extract shows promise as severe epilepsy treatment
Source: Epilepsy News From Medical News Today [2015.04.14]
A small study has trialled a marijuana extract in people with severe epilepsy. Seizures decreased among the participants, though 6% stopped taking the drug after side effects.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015